Novel biomarkers to assess mold exposure among children with asthma

Lalith K Silva1, Cody A Newman1, Idris J Wazeerud-Din1

  • 1Division of Laboratory Sciences, National Center for Environmental Health, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

Abstract

Insights

Serum 2-hexanone is a promising biomarker for recent household mold exposure. This finding supports public health investigations into indoor mold and its health impacts, especially in vulnerable communities.

Area of Science:

  • Environmental Health
  • Biomarker Discovery
  • Toxicology

Background:

  • Household mold is a significant environmental health concern, particularly after natural disasters like hurricanes or floods.
  • Water intrusion in homes can lead to mold growth, posing risks to occupants' health.
  • A reliable biomarker for indoor mold exposure is needed to aid public health investigations.

Purpose of the Study:

  • To identify potential biomarkers for recent indoor mold exposure in children with asthma.
  • To investigate the association between household mold and water damage and specific microbial volatile organic compounds (mVOCs) in serum.

Main Methods:

  • Serum samples from 132 children with asthma were analyzed for six mVOCs using gas chromatography-mass spectrometry (GC-MS).
  • Associations between reported mold/water damage and mVOC levels were assessed using regression analyses.
  • Urinary cotinine was measured to assess indoor tobacco smoke exposure as a potential confounder.

Main Results:

  • Children living in homes with reported mold or water damage had significantly higher serum concentrations of 2-hexanone (32% increase).
  • Higher urinary cotinine levels (indicating higher tobacco smoke exposure) were associated with elevated serum 2-ethyl-1-hexanol.
  • Reported indoor tobacco smoking was linked to higher serum 2-ethyl-1-hexanol levels.

Conclusions:

  • Serum 2-hexanone is a promising biomarker for recent household mold exposure.
  • An index of detectable mVOCs also shows potential as a biomarker for mold exposure.
  • These biomarkers could complement existing methods for assessing mold exposure in public health settings.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K